World’s First Coronavirus Vaccine Developed in Italy

Coronavirus (COVID-19) vaccine developed in Italy can neutralize the virus in human cells. The vaccine has generated antibodies mice that can work on human cells.

World’s first coronavirus vaccine has been successfully developed in Italy. Scientists in Italy have claimed that the vaccine works on humans by generating antibodies in mice.

Luigi Aurisicchio, CEO of Takis, the firm developing the medication, said that a coronavirus candidate vaccine has neutralised the virus in human cells for the first time, the Arab News reported.

Coronavirus
Coronaviruses infect animals, humans, and birds. Human coronaviruses, such as SARS, MERS, and 2019-nCoV cause respiratory distress and even death. The S protein is the infectious agent of the virus.

‘Coronavirus (COVID-19) vaccine developed in Italy can neutralize the virus in human cells. The vaccine has generated antibodies mice that can work on human cells.’

"This is the most advanced stage of testing of a candidate vaccine created in Italy. Human tests are expected after this summer," Aurisicchio was quoted as saying to Italian news agency ANSA.

"According to the Spallanzani Hospital, as far as we know we are the first in the world so far to have demonstrated neutralisation of the coronavirus by a vaccine. We expect this to happen in humans too," he added.

The researchers experimented with the vaccine on mice that had successfully developed antibodies that blocked the virus from infecting the cells. They further observed that the five vaccine candidates generated a large number of antibodies, and selected two with the best results.

Safe and Efficient SARS-coronavirus Vaccine Created
Scientists show how to modify an effective live attenuated severe acute respiratory syndrome (SARS) vaccine to make it genetically stable.

All of the vaccine candidates currently being developed are based on the genetic material of DNA protein "spike", the molecular tip used by the coronavirus to enter human cells.

They are injected with the so-called "electroporation" technique, which consists of an intramuscular injection followed by a brief electrical impulse, helping the vaccine break into the cells and activating the immune system, the report said.

US Very Close to Testing Coronavirus Vaccine, Says Trump
US President Donald Trump while addressing the daily White House coronavirus briefing said we are very close to a vaccine , after noting vaccine trials taking place in the US, Germany.

Researchers believe that this makes their vaccine particularly effective for generating functional antibodies against the "spike" protein, in particular in the lung cells, which are the most vulnerable to coronavirus.

"We are working hard for a vaccine coming from Italian research, with an all-Italian and innovative technology, tested in Italy and made available to everyone," Aurisicchio was quoted by the Arab News report.

Trial on Coronavirus Vaccine Starts Monday: Govt Official
The first participant in a clinical trial for a vaccine to protect against the new coronavirus will receive an experimental dose on Monday, according to a government official.

"In order to reach this goal, we need the support of national and international institutions and partners who may help us speed up the process," he noted.

The total number of Covid-19 infections, fatalities and recoveries since the pandemic began has risen to 213,013 in the country.

Source-IANS